Takeda E, Kuroda Y, Ito M, Toshima K, Watanabe T, Ito M, Naito E, Yokota I, Hwang T J, Miyao M
J Pediatr. 1985 Jul;107(1):71-4. doi: 10.1016/s0022-3476(85)80617-x.
The renal handling of urate was investigated in four children with hereditary renal hypouricemia and in their parents. The urate/creatinine clearance ratios in the four patients were 1.02 +/- 0.28, 0.93 +/- 0.11, 1.03 +/- 0.24, and 1.46 +/- 0.26, markedly higher than those in control subjects. Except for a partial response to pyrazinamide (change in clearance ratio from 1.46 to 1.07) in one patient, pyrazinamide and benzbromarone did not affect the clearance ratios in our patients. In the parents, the urate/creatinine clearance ratios were intermediate between those of the patients and control subjects, but responses to pyrazinamide and benzbromarone were normal. These data indicate that our patients have a combined defect in renal urate reabsorption, and that one of them might be subclassified as having the hypersecretion of defect. Results also show that heterozygotes can be identified by testing their urate/creatinine clearance ratio.
对4名患有遗传性低尿酸血症的儿童及其父母的尿酸肾脏处理情况进行了研究。4名患者的尿酸/肌酐清除率分别为1.02±0.28、0.93±0.11、1.03±0.24和1.46±0.26,明显高于对照组。除1例患者对吡嗪酰胺有部分反应(清除率从1.46变为1.07)外,吡嗪酰胺和苯溴马隆对我们的患者的清除率没有影响。在父母中,尿酸/肌酐清除率介于患者和对照组之间,但对吡嗪酰胺和苯溴马隆的反应正常。这些数据表明,我们的患者存在肾脏尿酸重吸收的联合缺陷,其中1例可能可归类为分泌缺陷型。结果还表明,杂合子可通过检测其尿酸/肌酐清除率来识别。